- Smoking cannabis produces combustion at approximately 900°C (1652°F), generating carbon monoxide, benzene, and polycyclic aromatic hydrocarbons (PAHs). Vaporization at 170–230°C avoids these byproducts.
- Vaping delivers higher THC bioavailability (50–80%) compared to smoking (25–50%), meaning the same gram of cannabis produces stronger effects when vaped.
- EVALI (e-cigarette or vaping product use associated lung injury), which peaked in 2019, was linked to vitamin E acetate in illicit THC cartridges—not cannabis vapor from legal products.
- Lower vaping temperatures (160–175°C) preserve more terpenes, improving flavor and potentially altering the effects profile via the entourage effect.
- Vaping produces less odor than smoking, making it more discreet in shared spaces.
- Upfront hardware cost is higher for vaping, but per-session cost is lower due to better efficiency.
How Smoking and Vaping Are Different
The fundamental difference between smoking and vaping cannabis is combustion. Smoking involves burning cannabis flower or concentrate at temperatures around 900°C (1652°F). At these temperatures, plant material undergoes pyrolysis—thermal decomposition that produces not only the desired cannabinoids and terpenes but hundreds of other compounds, many of them harmful. Vaporization, by contrast, heats cannabis to temperatures between 170°C and 230°C (338–446°F). These temperatures are high enough to volatilize cannabinoids and terpenes into a vapor but below the threshold for combustion.
The result is a delivery mechanism that extracts the active compounds from cannabis without the thermal degradation and toxic byproduct formation associated with burning. What the user inhales is vapor containing cannabinoids and terpenes rather than smoke containing those compounds mixed with combustion gases, tar, and particulates.
This distinction matters practically for three reasons: the health profile of what is inhaled, the efficiency with which active compounds are delivered, and the sensory experience of temperature-dependent compound extraction.
Health Comparison: What the Research Shows
The case for vaping over smoking from a respiratory health perspective rests on combustion chemistry. Cannabis smoke contains many of the same harmful compounds as tobacco smoke because combustion of organic matter produces similar byproducts regardless of the plant source. These include:
Carbon monoxide (CO): Produced by incomplete combustion of carbon-based material. CO binds to hemoglobin with 200 times the affinity of oxygen, reducing the blood’s oxygen-carrying capacity. CO is absorbed with every puff of smoked cannabis and is a major contributor to the cardiovascular strain associated with smoking.
Polycyclic aromatic hydrocarbons (PAHs): A family of compounds formed during combustion of organic material at high temperatures. PAHs include known carcinogens such as benzopyrene. Cannabis smoke has been shown to contain PAHs at concentrations comparable to tobacco smoke.
Benzene: A known human carcinogen formed during combustion. Present in cannabis smoke, absent or present at far lower levels in cannabis vapor from regulated vaporization temperatures.
Tar and particulates: Combustion produces fine particulate matter and tar—sticky residue that coats airways and contributes to bronchitis, chronic cough, and phlegm production. Vaporization dramatically reduces tar deposition.
Controlled studies comparing respiratory outcomes in cannabis smokers versus vapers consistently find that vapers report significantly fewer respiratory symptoms. A study published in the journal Harm Reduction found that switching from smoking to vaporizing cannabis was associated with improvements in respiratory symptoms including cough, phlegm production, and wheezing—even in long-term smokers.
However, vaping is not without unknowns. The long-term effects of inhaling cannabis vapor have not been studied over decades the way tobacco smoke has. Some compounds are generated at vaping temperatures that do not appear in room-temperature cannabis, though at levels far below those in smoke.
The EVALI Outbreak: What Actually Happened
In 2019, the United States experienced a significant outbreak of severe lung injury linked to vaping, which the CDC named EVALI (e-cigarette or vaping product use associated lung injury). At its peak, EVALI had hospitalized thousands and caused dozens of deaths, prompting widespread alarm about the safety of all cannabis vaping.
The CDC’s investigation identified the primary culprit: vitamin E acetate (tocopheryl acetate), a thickening agent used as a cutting agent in illicit THC oil cartridges. Vitamin E acetate is safe for skin application but, when inhaled, interferes with surfactant function in the lungs and causes lipoid pneumonia. It was found in the lung fluid of 94% of EVALI patients tested.
Critically, EVALI was almost exclusively linked to illicit market THC vape cartridges—not regulated cannabis products from licensed dispensaries, not dry-herb vaporizers, and not nicotine vaping products. Legal cannabis markets where product testing and labeling are required did not see the same outbreak patterns. The EVALI risk is real for those using unregulated vape cartridges; it is not meaningfully applicable to dry-herb vaporizers or tested legal products.
Effects Comparison
Beyond health, smoking and vaping produce noticeably different effects even at the same dose. This is primarily because vaping delivers a higher proportion of the available THC to the bloodstream.
| Factor | Smoking | Vaping |
|---|---|---|
| Onset | 30–90 seconds | 30–90 seconds |
| Duration | 1.5–3 hours | 1.5–2.5 hours |
| Intensity at same dose | Baseline | Higher (more THC delivered) |
| THC bioavailability | 25–50% | 50–80% |
| Terpene preservation | Low (combustion destroys terpenes) | High (especially at low temps) |
| Flavor | Smoke flavor dominates | Clear cannabis flavor |
| Respiratory irritation | High | Low to moderate |
The higher bioavailability of vaping is well documented. A landmark Johns Hopkins study found that vaporized cannabis produced significantly higher blood THC levels than the same dose of smoked cannabis and that inexperienced users reported stronger impairment from vaping. This is an important practical consideration: users transitioning from smoking to vaping should reduce their starting dose to account for increased efficiency.
Terpene Preservation and Flavor
One of the most significant advantages of vaporization, particularly at lower temperatures, is terpene preservation. Terpenes are the aromatic compounds responsible for the distinctive flavors and smells of different cannabis strains—the citrus of Lemon Haze, the earthiness of OG Kush, the pine of Jack Herer. Beyond flavor, terpenes are pharmacologically active and may contribute to the entourage effect.
Terpenes have relatively low boiling points. Many of the most flavorful and therapeutically interesting terpenes begin to volatilize around 160–175°C—well below the temperatures at which THC is maximally extracted. Combustion at 900°C destroys most terpenes before they can be inhaled. Vaporization at controlled lower temperatures captures terpenes in the vapor, delivering their flavor and potential effects alongside cannabinoids.
Users who vaporize at lower temperatures (160–180°C) often describe noticeably richer flavor profiles and describe the experience as cleaner and more nuanced than smoking. As temperature increases toward 220°C, the vapor becomes more cannabinoid-heavy, THC delivery increases, and the relative terpene contribution decreases.
Temperature Control in Vaping
One of vaping’s unique capabilities is precise temperature control, which allows users to dial in specific compounds. Different cannabinoids and terpenes have different boiling points, so temperature selection shapes the experience.
| Temperature | Fahrenheit | What Is Activated | Effect Profile |
|---|---|---|---|
| 160°C | 320°F | Myrcene, other low-boiling terpenes | Light, terpene-forward, mild |
| 175°C | 347°F | THC begins to volatilize; limonene, linalool | Balanced, flavorful, functional |
| 185°C | 365°F | CBD, CBN begin to volatilize; THC peak | Full effects, good for pain and anxiety |
| 200°C | 392°F | CBC, CBG, higher-boiling terpenes | Stronger, more sedating, less flavor |
| 220°C | 428°F | Maximum extraction before combustion | Most potent vapor; harsher |
| 230°C+ | 446°F+ | Combustion begins | Smoke, not vapor; avoid |
Cost Comparison
The economics of smoking versus vaping are often misunderstood. The common perception is that vaping is expensive, and on an upfront hardware basis, this is true. A quality portable dry-herb vaporizer (Mighty+, Arizer, PAX) costs $150–$400. A quality desktop vaporizer costs $200–$700. By contrast, papers, pipes, and other smoking equipment cost very little.
However, per-session costs tell a different story. Because vaping delivers more THC per gram (50–80% bioavailability versus 25–50% for smoking), the same quantity of cannabis produces more sessions when vaped than when smoked. Users who switch from smoking to vaping frequently report using 30–50% less cannabis to achieve the same effect. Over months of use, a quality vaporizer typically pays for itself in cannabis savings.
Additionally, already-vaped bud (AVB) retains residual cannabinoids that have not been fully decarboxylated. AVB can be used to make edibles or capsules, adding another layer of efficiency to vaping that smoking cannot match.
Discretion and Odor
Cannabis odor is one of the most practically significant differences between smoking and vaping. Burning cannabis produces a strong, persistent odor that permeates clothing, furniture, and enclosed spaces and lingers long after the session ends. This odor is primarily from terpenes being burned and from smoke particles that cling to surfaces.
Vaping produces significantly less odor. Vapor dissipates faster than smoke, contains fewer heavy particulates, and at lower temperatures produces a cleaner, less pungent smell. The odor from vaping is still detectable to those nearby, particularly at higher temperatures, but it fades quickly and is generally far less intrusive than smoke.
For users in apartments, shared living spaces, or areas where cannabis odor is socially problematic, vaping offers meaningful advantages. Compact portable vaporizers also produce less visible vapor cloud than larger sessions of smoking, offering additional discretion in public or semi-private settings.
Which Is Better? Pros and Cons Summary
| Factor | Smoking | Vaping |
|---|---|---|
| Respiratory health | Higher risk (combustion byproducts) | Lower risk (no combustion) |
| Upfront cost | Very low | Higher ($150–$400+) |
| Per-session efficiency | Lower (25–50% bioavailability) | Higher (50–80% bioavailability) |
| Flavor | Smoke flavor | Clean terpene-forward flavor |
| Odor | Strong, persistent | Mild, dissipates quickly |
| Temperature control | None | Precise (key advantage) |
| Ease of use | Simple, no learning curve | Requires device and maintenance |
| Portability | High (papers/pipe) | Good (portable vapes) |
| Legal cartridge risk | N/A | Low (legal products); avoid illicit carts |
Neither method is without trade-offs. Smoking is simpler, cheaper upfront, and social—but involves combustion byproducts that negatively affect respiratory health over time. Vaping is more efficient, better for respiratory health, and offers temperature control, but requires a hardware investment and carries its own unknowns, particularly with unregulated products. For users who prioritize health, flavor, and efficiency, a quality dry-herb vaporizer is the clearly superior option once the initial cost barrier is crossed.
Frequently Asked Questions
Is vaping cannabis safer than smoking?
Based on available evidence, vaping cannabis from legal regulated products produces fewer toxic combustion byproducts than smoking and is associated with fewer respiratory symptoms. However, long-term vaping effects are still under study. The EVALI outbreak was caused by vitamin E acetate in illicit cartridges, not cannabis vapor from legal, tested products.
Do you get higher from vaping or smoking?
Vaping generally delivers more THC per gram consumed (50–80% bioavailability vs 25–50% for smoking). Most users report stronger effects from vaping at the same dose. Users switching from smoking to vaping should reduce their starting dose to account for the increased efficiency.
What temperature should I vape cannabis?
For balanced effects, 175–185°C (347–365°F) is a good starting range. Lower temperatures (160–175°C) emphasize terpenes and produce lighter, more functional effects. Higher temperatures (185–220°C) extract more cannabinoids for stronger effects. Avoid exceeding 230°C to prevent combustion.
What is the EVALI risk from cannabis vaping?
EVALI peaked in the US in 2019 and was linked by the CDC to vitamin E acetate in illicit THC cartridges, not regulated cannabis products. Legal cannabis vaping products from licensed dispensaries that undergo testing have not been linked to EVALI. To minimize risk, avoid illicit market vape cartridges entirely.